User profiles for "author:Giuseppe Mancia"

Giuseppe Mancia

Emeritus Professor, Università Bicocca - Milan ITALY
Verified email at UNIMIB.IT
Cited by 208782

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of …

B Williams, G Mancia, W Spiering… - European heart …, 2018 - academic.oup.com
Aims The expression of GADD153 (growth arrest and DNA damage-inducible gene 153), an
apoptosis-regulated gene, increases during endoplasmic reticulum (ER) stress. How …

European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement

E O'brien, R Asmar, L Beilin, Y Imai… - Journal of …, 2003 - journals.lww.com
Blood pressure measurement is the basis for the diagnosis, management, treatment,
epidemiology and research of hypertension, and the decisions affecting these aspects of …

Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation: a critical appraisal

G Parati, JP Saul, M Di Rienzo, G Mancia - Hypertension, 1995 - Am Heart Assoc
Blood pressure variability includes rhythmic and nonrhythmic fluctuations that, with the use
of spectral analysis, appear as clear peaks or broadband power, respectively. This review …

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension …

G Mancia, G De Backer, A Dominiczak… - European heart …, 2007 - academic.oup.com
Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and …

I Graham, D Atar, K Borch-Johnsen… - European heart …, 2007 - academic.oup.com
†European guidelines on cardiovascular disease prevention in clinical practice: executive
summary | European Heart Journal | Oxford Academic Skip to Main Content Advertisement …

European guidelines on cardiovascular disease prevention in clinical practice; third joint task force of European and other societies on cardiovascular disease …

G De Backer, E Ambrosioni… - European Journal of …, 2003 - academic.oup.com
Preamble Guidelines aim to present all the relevant evidence on a particular issue in order
to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic …

2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension

G Mancia, G De Backer, A Dominiczak… - Journal of …, 2007 - journals.lww.com
2007 ESH-ESC Practice Guidelines for the Management of Arter... : Journal of Hypertension
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC …

[HTML][HTML] Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

G Mancia, S Laurent, E Agabiti-Rosei… - Blood …, 2009 - Taylor & Francis
GIUSEPPE MANCIAa, STÉPHANE LAURENTb, ENRICO AGABITI-ROSEIc, ETTORE
AMBROSIONId, MICHEL BURNIERe, MARK J. CAULFIELDf, RENATA CIFKOVAg, DENIS …

Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies* on Coronary …

D Wood, G De Backer, O Faergeman… - Journal of …, 1998 - journals.lww.com
Since the first Joint European Societies (European Society of Cardiology, European
Atherosclerosis Society and European Society of Hypertension) Task Force …

[HTML][HTML] Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an …

K Rahimi, Z Bidel, M Nazarzadeh, E Copland, D Canoy… - The Lancet, 2021 - thelancet.com
Background The effects of pharmacological blood pressure lowering at normal or high-
normal blood pressure ranges in people with or without pre-existing cardiovascular disease …